Literature DB >> 15895592

Distributions of beta+ decayed nuclei generated in the CH2 and H2O targets by the target nuclear fragment reaction using therapeutic MONO and SOBP proton beam.

Teiji Nishio1, Takashi Sato, Hideaki Kitamura, Koji Murakami, Takashi Ogino.   

Abstract

In proton radiotherapy, the irradiation dose can be concentrated on a tumor. To use this radiotherapy efficiently in the clinical field, it is necessary to evaluate the proton-irradiated area and condition. The proton-irradiated area can be confirmed by coincidence detection of pair annihilation gamma rays from beta+ decayed nuclei generated by target nuclear fragment reaction of irradiated proton nuclei and nuclei in the irradiation target. In this study, we performed experiments of proton irradiation to a polyethylene (PE:CH2) target containing 12C nuclei, which is a major component of the human body, and a gelatinous water (H2O) target containing 16O nuclei at different proton irradiation energy levels under different beam conditions of mono-energetic Bragg peak and spread-out Bragg peak. The distribution of the activity in the target after proton irradiation was measured by a positron emission tomography (PET) apparatus, and compared with the calculated distribution. The temporal dependence of the activity distribution during the period between the completion of proton irradiation and the start of measurement by the PET apparatus was examined. The activity by clinical proton irradiation was 3 kB/cc in the PE target and 13 kB/cc in the water target, indicating that the intensity was sufficient for the evaluation of the distribution. The range of the activity distribution against the physical range was short (several millimeter water equivalent length), indicating the presence of target dependence. The range difference in the water target was slightly large with time dependence until the start of measurement. The difference of the lateral widths with full width half at maximum in the distributions of the measured irradiated dose and activity was within 1 mm.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15895592     DOI: 10.1118/1.1879692

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  17 in total

1.  Nuclear collision processes around the Bragg peak in proton therapy.

Authors:  Yuka Matsuzaki; Hiroyuki Date; Kenneth Lee Sutherland; Yoshiaki Kiyanagi
Journal:  Radiol Phys Technol       Date:  2009-12-29

2.  Improved MAGIC gel for higher sensitivity and elemental tissue equivalent 3D dosimetry.

Authors:  Xuping Zhu; Timothy G Reese; Elizabeth M Crowley; Georges El Fakhri
Journal:  Med Phys       Date:  2010-01       Impact factor: 4.071

3.  Experimental verification of the utility of positron emitter nuclei generated by photonuclear reactions for X-ray beam monitoring in a phantom.

Authors:  Teiji Nishio; Taku Inaniwa; Kazumasa Inoue; Aya Miyatake; Keiichi Nakagawa; Kiyoshi Yoda; Takashi Ogino
Journal:  Radiat Med       Date:  2007-12-25

4.  Clinical CT-based calculations of dose and positron emitter distributions in proton therapy using the FLUKA Monte Carlo code.

Authors:  K Parodi; A Ferrari; F Sommerer; H Paganetti
Journal:  Phys Med Biol       Date:  2007-05-17       Impact factor: 3.609

5.  Optimizing a three-stage Compton camera for measuring prompt gamma rays emitted during proton radiotherapy.

Authors:  S W Peterson; D Robertson; J Polf
Journal:  Phys Med Biol       Date:  2010-11-03       Impact factor: 3.609

6.  Feasibility study of using fall-off gradients of early and late PET scans for proton range verification.

Authors:  Jongmin Cho; Kira Grogg; Chul Hee Min; Xuping Zhu; Harald Paganetti; Hyun Cheol Lee; Georges El Fakhri
Journal:  Med Phys       Date:  2017-03-30       Impact factor: 4.071

7.  Proton therapy dosimetry using positron emission tomography.

Authors:  Matthew T Studenski; Ying Xiao
Journal:  World J Radiol       Date:  2010-04-28

8.  PET/CT imaging for treatment verification after proton therapy: a study with plastic phantoms and metallic implants.

Authors:  Katia Parodi; Harald Paganetti; Ethan Cascio; Jacob B Flanz; Ali A Bonab; Nathaniel M Alpert; Kevin Lohmann; Thomas Bortfeld
Journal:  Med Phys       Date:  2007-02       Impact factor: 4.071

9.  Feasibility of proton-activated implantable markers for proton range verification using PET.

Authors:  Jongmin Cho; Geoffrey Ibbott; Michael Gillin; Carlos Gonzalez-Lepera; Uwe Titt; Harald Paganetti; Matthew Kerr; Osama Mawlawi
Journal:  Phys Med Biol       Date:  2013-10-08       Impact factor: 3.609

10.  Determination of elemental tissue composition following proton treatment using positron emission tomography.

Authors:  Jongmin Cho; Geoffrey Ibbott; Michael Gillin; Carlos Gonzalez-Lepera; Chul Hee Min; Xuping Zhu; Georges El Fakhri; Harald Paganetti; Osama Mawlawi
Journal:  Phys Med Biol       Date:  2013-05-16       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.